114 related articles for article (PubMed ID: 26551939)
1. Mechanisms of LtxA (Leukotoxin), a Potent New Anti-Inflammatory Agent for the Treatment of Alopecia Areata.
Kachlany SC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):19-22. PubMed ID: 26551939
[TBL] [Abstract][Full Text] [Related]
2. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.
DiFranco KM; Gupta A; Galusha LE; Perez J; Nguyen TK; Fineza CD; Kachlany SC
J Biol Chem; 2012 May; 287(21):17618-17627. PubMed ID: 22467872
[TBL] [Abstract][Full Text] [Related]
3. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
4.
Vega BA; Belinka BA; Kachlany SC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
[No Abstract] [Full Text] [Related]
5. Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.
Gupta A; Espinosa V; Galusha LE; Rahimian V; Miro KL; Rivera-Medina A; Kasinathan C; Capitle E; Aguila HA; Kachlany SC
J Leukoc Biol; 2015 Mar; 97(3):439-46. PubMed ID: 25341726
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Gupta A; Le A; Belinka BA; Kachlany SC
Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
[TBL] [Abstract][Full Text] [Related]
7. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
Kaur M; Kachlany SC
Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
[TBL] [Abstract][Full Text] [Related]
8. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
9. Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model.
Stenderup K; Rosada C; Dam TN; Salerno E; Belinka BA; Kachlany SC
J Invest Dermatol; 2011 Oct; 131(10):2033-9. PubMed ID: 21654835
[TBL] [Abstract][Full Text] [Related]
10. Leukotoxin (LtxA/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes.
Prince DJ; Patel D; Kachlany SC
Sci Rep; 2021 Sep; 11(1):18086. PubMed ID: 34508147
[TBL] [Abstract][Full Text] [Related]
11. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J
Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730
[TBL] [Abstract][Full Text] [Related]
12. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
14. [Clinical case of a combination of ulcerative colitis and alopecia areata].
Safina DD; Abdulkhakov RA; Abdulkhakov SR; Odintsova AKh; Cheremina NA
Eksp Klin Gastroenterol; 2013; (12):92-6. PubMed ID: 24933997
[TBL] [Abstract][Full Text] [Related]
15. Overview of alopecia areata.
Hordinsky MK
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
[TBL] [Abstract][Full Text] [Related]
16. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
17. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
18. Treatment of alopecia areata: "What is new on the horizon?".
Hordinsky MK
Dermatol Ther; 2011; 24(3):364-8. PubMed ID: 21689246
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of alopecia areata: modern principles and perspectives].
Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
[TBL] [Abstract][Full Text] [Related]
20. Alopecia areata susceptibility in rodent models.
McElwee KJ; Freyschmidt-Paul P; Zöller M; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):182-7. PubMed ID: 14582670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
